Insider Transactions in Q2 2024 at Boston Scientific Corp (BSX)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 03
2024
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
6,983
-13.27%
|
$523,725
$75.33 P/Share
|
|
Jun 03
2024
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
4,263
+3.93%
|
$85,260
$20.91 P/Share
|
|
May 29
2024
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Open market or private sale
|
Direct |
63,802
-69.48%
|
$4,785,150
$75.1 P/Share
|
|
May 29
2024
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
33,726
+26.86%
|
$573,342
$17.26 P/Share
|
|
May 28
2024
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Open market or private sale
|
Direct |
14,011
-40.96%
|
$1,050,825
$75.34 P/Share
|
|
May 28
2024
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
4,186
+5.8%
|
$79,534
$19.99 P/Share
|
|
May 23
2024
|
Daniel J. Brennan EVP and CFO |
SELL
Open market or private sale
|
Direct |
47,621
-17.54%
|
$3,571,575
$75.11 P/Share
|
|
May 22
2024
|
Daniel J. Brennan EVP and CFO |
SELL
Open market or private sale
|
Direct |
64,454
-19.18%
|
$4,834,050
$75.91 P/Share
|
|
May 22
2024
|
Daniel J. Brennan EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
64,454
+4.93%
|
$1,353,534
$21.3 P/Share
|
|
May 22
2024
|
Vance R Brown SVP, GC and Corp. Secretary |
SELL
Open market or private sale
|
Direct |
15,006
-31.7%
|
$1,140,456
$76.01 P/Share
|
|
May 22
2024
|
Vance R Brown SVP, GC and Corp. Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
15,006
+24.07%
|
$405,162
$27.09 P/Share
|
|
May 21
2024
|
Vance R Brown SVP, GC and Corp. Secretary |
SELL
Open market or private sale
|
Direct |
18,037
-35.81%
|
$1,352,775
$75.6 P/Share
|
|
May 21
2024
|
Vance R Brown SVP, GC and Corp. Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
18,037
+26.37%
|
$432,888
$24.55 P/Share
|
|
May 13
2024
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Bona fide gift
|
Direct |
2,380
-1.23%
|
-
|
|
May 10
2024
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
SELL
Open market or private sale
|
Direct |
12,931
-29.16%
|
$956,894
$74.14 P/Share
|
|
May 10
2024
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
BUY
Exercise of conversion of derivative security
|
Direct |
12,931
+22.57%
|
$206,896
$16.31 P/Share
|
|
May 09
2024
|
Charles J Dockendorff Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,901
+50.0%
|
-
|
|
May 09
2024
|
Yoshiaki Fujimori Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,901
+50.0%
|
-
|
|
May 09
2024
|
Susan E Morano Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,871
+19.36%
|
-
|
|
May 09
2024
|
Edward J Ludwig Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,901
+6.15%
|
-
|
|
May 09
2024
|
Jessica L Mega Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,901
+32.04%
|
-
|
|
May 09
2024
|
John E Sununu Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,901
+5.22%
|
-
|
|
May 09
2024
|
David S Wichmann Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,901
+6.84%
|
-
|
|
May 09
2024
|
Ellen M Zane Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,901
+5.64%
|
-
|
|
May 07
2024
|
Charles J Dockendorff Director |
SELL
Open market or private sale
|
Direct |
3,946
-100.0%
|
$284,112
$72.7 P/Share
|
|
May 02
2024
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Payment of exercise price or tax liability
|
Direct |
1,017
-3.28%
|
$73,224
$72.03 P/Share
|
|
May 02
2024
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
2,102
+6.34%
|
-
|
|
May 02
2024
|
John Bradley Sorenson EVP, Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,917
-3.5%
|
$138,024
$72.03 P/Share
|
|
May 02
2024
|
John Bradley Sorenson EVP, Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
4,203
+7.12%
|
-
|
|
May 01
2024
|
John Bradley Sorenson EVP, Global Operations |
SELL
Open market or private sale
|
Direct |
17,587
-25.78%
|
$1,248,677
$71.5 P/Share
|
|
May 01
2024
|
John Bradley Sorenson EVP, Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
17,587
+20.49%
|
$298,979
$17.26 P/Share
|
|
May 01
2024
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
6,983
-12.62%
|
$495,793
$71.47 P/Share
|
|
May 01
2024
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
4,263
+3.74%
|
$85,260
$20.91 P/Share
|
|
Apr 26
2024
|
Edward J Ludwig Director |
SELL
Open market or private sale
|
Direct |
9,818
-19.18%
|
$716,714
$73.29 P/Share
|
|
Apr 26
2024
|
Edward J Ludwig Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,818
+16.09%
|
$166,906
$17.37 P/Share
|
|
Apr 01
2024
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
6,983
-12.03%
|
$474,844
$68.42 P/Share
|
|
Apr 01
2024
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
4,263
+3.57%
|
$85,260
$20.91 P/Share
|
|
Apr 01
2024
|
John Bradley Sorenson EVP, Global Operations |
SELL
Open market or private sale
|
Direct |
16,351
-24.41%
|
$1,128,219
$69.3 P/Share
|
|
Apr 01
2024
|
John Bradley Sorenson EVP, Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
16,351
+19.62%
|
$261,616
$16.31 P/Share
|